Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides. 2000-Present.

Advances in Carbohydrate Chemistry and Biochemistry

Volumn 67, Issue , 2012, Pages 95-136

  Dulaney, Steven B ^a   Huang, Xuefei ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Chemoselectivity; Heparan sulfate; Heparin; Synthetic methods

Indexed keywords

FONDAPARINUX; HEPARAN SULFATE; HEPARIN; IDURONIC ACID; OLIGOSACCHARIDE; POLYMER; PYRANOSIDE; URONIC ACID;

ARTICLE; DRUG SYNTHESIS; ENZYME SYNTHESIS; GLYCOSYLATION; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 84863879494     PISSN: 00652318     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396527-1.00003-6     Document Type: Chapter

References (116)

1. Linhardt R.J. Heparin: An important drug enters its seventh decade. Chem. Ind. 1991, 45-47.
2. Cifonelli J.A., Dorfman A. Uronic acid of heparin. Biochem. Biophys. Res. Commun. 1962, 7:41-45.
3. Hook M., Bjork I., Hopwood J., Lindahl U. Anticoagulant activity of heparin: Separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett. 1976, 66:90-93.
4. Damus P.S., Hicks M., Rosenberg R.D. Anticoagulant action of heparin. Nature 1973, 246:355-357.
5. Gandhi N.S., Mancera R.L. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 2008, 72:455-482.
6. Seeberger P.H., Werz D.B. Synthesis and medical applications of oligosaccharides. Nature 2007, 446:1046-1051.
7. Parish C.R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 2006, 6:633-643.
8. Powell A.K., Yates E.A., Fernig D.G., Turnbull J.E. Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches. Glycobiology 2004, 14:17R-30R.
9. Sasisekharan R., Shriver Z., Venkataraman G., Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2002, 2:521-528.
10. Liu D., Shriver Z., Qi Y., Venkataraman G., Sasisekharan R. Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin. Thromb. Hemost. 2002, 28:67-78.
11. Casu B., Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 2001, 57:159-206.
12. Sanderson R.D. Heparan sulfate proteoglycans in invasion and metastasis. Semin. Cell Dev. Biol. 2001, 12:89-98.
13. Casu B. Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 1985, 43:51-134.
14. Esko J.D., Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 2001, 108:169-173.
15. Gallagher J.T., Walker A. Molecular distinctions between heparan sulfate and heparin. Analysis of sulfation patterns indicates that heparan sulfate and heparin are separate families of N-sulfated polysaccharides. Biochem. J. 1985, 230:665-674.
16. Lindahl U., Kjellen L. Heparin or heparan sulfate-What is the difference?. Thromb. Haemostasis 1991, 66:44-48.
17. Lam L.H., Silbert J.E., Rosenberg R.D. The separation of active and inactive forms of heparin. Biochem. Biophys. Res. Commun. 1976, 69:570-577.
18. Lindahl U., Baeckstroem G., Hoeoek M., Thunberg L., Fransson L.-A., Linker A. Structure of the antithrombin-binding site in heparin. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:3198-3202.
19. Rosenberg R.D., Lam L. Correlation between structure and function of heparin. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:1218-1222.
20. Petitou M., Casu B., Lindahl U. 1976-1983, a critical period in the history of heparin: The discovery of the antithrombin binding site. Biochimie 2003, 85:83-89.
21. Petitou M., van Boeckel C.A.A. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?. Angew. Chem. Int. Ed. 2004, 43:3118-3133.
22. Petitou M., Duchaussoy P., Lederman I., Choay J., Sinaÿ P. Binding of heparin to antithrombin III: A chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-D-glucose residue. Carbohydr. Res. 1988, 179:163-172.
23. Ishihara M., Kariya Y., Kikuchi H., Minamisawa T., Yoshida K. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. 1997, 121:345-349.
24. Ishihara M., Takano R., Kanda T., Hayashi K., Hara S., Kikuchi H., Yoshida K. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. 1995, 118:1255-1260.
25. Noti C., Seeberger P.H. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Chem. Biol. 2005, 12:731-756.
26. Noti C., Seeberger P.H. Synthetic approach to define structure-activity relationship of heparin and heparan sulfate. Chemistry and Biology of Heparin and Heparan Sulfate 2005, 79-142. Elsevier, Oxford. H.G. Garg, R.J. Linhardt, C.A. Hales (Eds.).
27. Codée J.D.C., Overkleeft H.S., van der Marel G.A., van Boeckel C.A.A. The synthesis of well-defined heparin and heparan sulfate fragments. Drug Discov. Today Technol. 2004, 1:317-326.
28. Karst N.A., Linhardt R.J. Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides. Curr. Med. Chem. 2003, 10:1993-2031.
29. Poletti L., Lay L. Chemical contributions to understanding heparin activity: Synthesis of related sulfated oligosaccharides. Eur. J. Org. Chem. 2003, 2999-3024.
30. Sinaÿ P., Jacquinet J.C., Petitou M., Duchaussoy P., Lederman I., Choay J., Torri G. Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III. Carbohydr. Res. 1984, 132:C5-C9.
31. Van Boeckel C.A.A., Beetz T., Vos J.N., de Jong A.J.M., van Aelst S.F., van den Bosch R.H., Mertens J.M.R., van der Vlugt F.A. Synthesis of a pentasaccharide corresponding to the antithrombin III binding fragment of heparin. J. Carbohydr. Chem. 1985, 4:293-321.
32. Tatai J., Osztrovszky G., Kajtar-Peredy M., Fügedi P. An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides. Carbohydr. Res. 2008, 343:596-606.
33. Hansen S.U., Barath M., Salameh B.A.B., Pritchard R.G., Stimpson W.T., Gardiner J.M., Jayson G.C. Scalable synthesis of L-iduronic acid derivatives via stereocontrolled cyanohydrin reaction for synthesis of heparin-related disaccharides. Org. Lett. 2009, 11:4528-4531.
34. Dilhas A., Bonnaffe D. Efficient selective preparation of methyl-1,2,4-tri-O-acetyl-3-O-benzyl-β-L-idopyranuronate from methyl 3-O-benzyl-L-iduronate. Carbohydr. Res. 2003, 338:681-686.
35. Hung S.-C., Thopate S.R., Chi F.-C., Chang S.-W., Lee J.-C., Wang C.-C., Wen Y.-S. 1,6-Anhydro-β-L-hexopyranoses as potent synthons in the synthesis of the disaccharide units of bleomycin A2 and heparin. J. Am. Chem. Soc. 2001, 123:3153-3154.
36. Hung S.-C., Puranik R., Chi F.-C. Novel synthesis of 1,2:3,5-di-O-isopropylidene-β-L-idofuranoside and its derivatives at C6. Tetrahedron Lett. 2000, 41:77-80.
37. Saito A., Wakao M., Deguchi H., Mawatari A., Sobel M., Suda Y. Toward the assembly of heparin and heparan sulfate oligosaccharide libraries: Efficient synthesis of uronic acid and disaccharide building blocks. Tetrahedron 2010, 66:3951-3962.
38. Adibekian A., Bindschaedler P., Timmer M.S.M., Noti C., Schuetzenmeister N., Seeberger P.H. De Novo synthesis of uronic acid building blocks for assembly of heparin oligosaccharides. Chem. Eur. J. 2007, 13:4510-4522.
39. Timmer M.S.M., Adibekian A., Seeberger P.H. Short de novo synthesis of fully functionalized uronic acid monosaccharides. Angew. Chem. Int. Ed. 2005, 44:7605-7607.
40. Yu H.N., Furukawa J., Ikeda T., Wong C.-H. Novel efficient routes to heparin monosaccharides and disaccharides achieved via regio- and stereoselective glycosidation. Org. Lett. 2004, 6:723-726.
41. Gavard O., Hersant Y., Alais J., Duverger V., Dilhas A., Bascou A., Bonnaffe D. Efficient preparation of three building blocks for the synthesis of heparan sulfate fragments: Towards the combinatorial synthesis of oligosaccharides from hypervariable regions. Eur. J. Org. Chem. 2003, 3603-3620.
42. Ke W., Whitfield D.M., Gill M., Larocque S., Yu S.-H. A short route to L-iduronic acid building blocks for the syntheses of heparin-like disaccharides. Tetrahedron Lett. 2003, 44:7767-7770.
43. Schell P., Orgueira H.A., Roehrig S., Seeberger P.H. Synthesis and transformations of D-glucuronic and L-iduronic acid glycals. Tetrahedron Lett. 2001, 42:3811-3814.
44. Lubineau A., Gavard O., Alais J., Bonnaffe D. New accesses to L-iduronyl synthons. Tetrahedron Lett. 2000, 41:307-311.
45. Fernandez R., Martin-Zamora E., Pareja C., Lassaletta J.M. Stereoselective nucleophilic formylation and cyanation of α-alkoxy- and α-aminoaldehydes. J. Org. Chem. 2001, 66:5201-5207.
46. Huang L., Huang X. Highly efficient syntheses of hyaluronic acid oligosaccharides. Chem. Eur. J. 2007, 13:529-540.
47. Huang L., Teumelsan N., Huang X. A facile method for oxidation of primary alcohols to carboxylic acids and its application in glycosaminoglycan syntheses. Chem. Eur. J. 2006, 12:5246-5252.
48. Palmacci E.R., Seeberger P.H. Toward the modular synthesis of glycosaminoglycans: Synthesis of hyaluronic acid disaccharide building blocks using a periodic acid oxidation. Tetrahedron 2004, 60:7755-7766.
49. La Ferla B., Lay L., Guerrini M., Poletti L., Panza L., Russo G. Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharides. Tetrahedron 1999, 55:9867-9880.
50. Tabeur C., Mallet J.M., Bono F., Herbert J.M., Petitou M., Sinaÿ P. Oligosaccharides corresponding to the regular sequence of heparin: Chemical synthesis and interaction with FGF-2. Bioorg. Med. Chem. 1999, 7:2003-2012.
51. Kovensky J., Duchaussoy P., Bono F., Salmivirta M., Sizun P., Herbert J.-M., Petitou M., Sinaÿ P. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers. Bioorg. Med. Chem. 1999, 7:1567-1580.
52. Haller M., Boons G.-J. Towards a modular approach for heparin synthesis. J. Chem. Soc. Perkin Trans. 1 2001, 814-822.
53. de Nooy A.E.J., Besemer A.C., van Bekkum H. Highly selective nitroxyl radical-mediated oxidation of primary alcohol groups in water-soluble glucans. Carbohydr. Res. 1995, 269:89-96.
54. Davis N.J., Flitsch S.L. Selective oxidation of monosaccharide derivatives to uronic acids. Tetrahedron Lett. 1993, 34:1181-1184.
55. Hu Y.-P., Lin S.-Y., Huang C.-Y., Zulueta M.M.L., Liu J.-Y., Chang W., Hung S.-C. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction. Nat. Chem. 2011, 3:557-563.
56. van den Bos L.J., Codée J.D.C., van der Toorn J.C., Boltje T.J., van Boom J.H., Overkleeft H.S., van der Marel G.A. Thio-glycuronides: Synthesis and application in the assembly of acidic oligosaccharides. Org. Lett. 2004, 6:2165-2168.
57. Tiruchinapally G., Yin Z., El-Dakdouki M., Wang Z., Huang X. Divergent heparin oligosaccharide synthesis with pre-installed sulfate esters. Chem. Eur. J. 2011, 17:10106-10112.
58. Wang Z., Xu Y., Yang B., Tiruchinapally G., Sun B., Liu R., Dulaney S., Liu J., Huang X. Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions. Chem. Eur. J. 2010, 16:8365-8375.
59. Arungundram S., Al-Mafraji K., Asong J., Leach F.E., Amster I.J., Venot A., Turnbull J.E., Boons G.-J. Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies. J. Am. Chem. Soc. 2009, 131:17394-17405.
60. Chen J., Zhou Y., Chen C., Xu W., Yu B. Synthesis of a tetrasaccharide substrate of heparanase. Carbohydr. Res. 2008, 343:2853-2862.
61. Walvoort M.T.C., de Witte W., van Dijk J., Dinkelaar J., Lodder G., Overkleeft H.S., Codée J.D.C., van der Marel G.A. Mannopyranosyl uronic acid donor reactivity. Org. Lett. 2011, 13:4360-4363.
62. Zeng Y., Wang Z., Whitfield D., Huang X. Installation of electron-donating protective groups, a strategy for glycosylating unreactive thioglycosyl acceptors using the preactivation-based glycosylation method. J. Org. Chem. 2008, 73:7952-7962.
63. 2 promoted reductive opening of 2',4'-O-p-methoxybenzylidene: New regioselective differentiation of position 2' and 4' of α-L-iduronyl moieties in disaccharide building blocks. Tetrahedron Lett. 2004, 45:3643-3645.
64. Baleux F., Loureiro-Morais L., Hersant Y., Clayette P., Arenzana-Seisdedos F., Bonnaffe D., Lortat-Jacob H. A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Nat. Chem. Biol. 2009, 5:743-748.
65. Paulsen H. Progress in the selective chemical synthesis of complex oligosaccharides. Angew. Chem. Int. Ed. 1982, 21:155-173.
66. Codée J.D.C., Stubba B., Schiattarella M., Overkleeft H.S., van Boeckel C.A.A., van Boom J.H., van der Marel G.A. A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy. J. Am. Chem. Soc. 2005, 127:3767-3773.
67. Orgueira H.A., Bartolozzi A., Schell P., Litjens R.E.J.N., Palmacci E.R., Seeberger P.H. Modular synthesis of heparin oligosaccharides. Chem. Eur. J. 2003, 9:140-169.
68. Orgueira H.A., Bartolozzi A., Schell P., Seeberger P.H. Conformational locking of the glycosyl acceptor for stereocontrol in the key step in the synthesis of heparin. Angew. Chem. Int. Ed. 2002, 41:2128-2131.
69. Lohman G.J.S., Seeberger P.H. A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups. J. Org. Chem. 2004, 69:4081-4093.
70. Lu L.-D., Shie C.-R., Kulkarni S.S., Pan G.-R., Lu X.-A., Hung S.-C. Synthesis of 48 disaccharide building blocks for the assembly of a heparin and heparan sulfate oligosaccharide library. Org. Lett. 2006, 8:5995-5998.
71. Fan R.-H., Achkar J., Hernandez-Torres J.M., Wei A. Orthogonal sulfation strategy for synthetic heparan sulfate ligands. Org. Lett. 2005, 7:5095-5098.
72. Lee J.-C., Lu X.-A., Kulkarni S.S., Wen Y.-S., Hung S.-C. Synthesis of heparin oligosaccharides. J. Am. Chem. Soc. 2004, 126:476-477.
73. Noti C., de Paz J.L., Polito L., Seeberger P.H. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Chem. Eur. J. 2006, 12:8664-8686.
74. Huibers M., Manuzi A., Rutjes F.P.J.T., van Delft F.L. A sulfitylation-oxidation protocol for the preparation of sulfates. J. Org. Chem. 2006, 71:7473-7476.
75. Simpson L.S., Widlanski T.S. A comprehensive approach to the synthesis of sulfate esters. J. Am. Chem. Soc. 2006, 128:1605-1610.
76. Karst N.A., Islam T.F., Linhardt R.J. Sulfo-protected hexosamine monosaccharides: Potentially versatile building blocks for glycosaminoglycan synthesis. Org. Lett. 2003, 5:4839-4842.
77. Ingram L.J., Taylor S.D. Introduction of 2,2,2-trichloroethyl-protected sulfates into monosaccharides with a sulfuryl imidazolium salt and application to the synthesis of sulfated carbohydrates. Angew. Chem. Int. Ed. 2006, 45:3503-3506.
78. Kreuger J., Salmivirta M., Sturiale L., Gimenez-Gallego G., Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 2001, 276:30744-30752.
79. Tatai J., Fügedi P. Synthesis of the putative minimal FGF binding motif heparan sulfate trisaccharides by an orthogonal protecting group strategy. Tetrahedron 2008, 64:9865-9873.
80. Weishaupt M., Eller S., Seeberger P.H. Solid phase synthesis of oligosaccharides. Methods Enzymol. 2010, 478:463-484.
81. Plante O.J., Palmacci E.R., Seeberger P.H. Automated solid-phase synthesis of oligosaccharides. Science 2001, 291:1523-1527.
82. Czechura P., Guedes N., Kopitzki S., Vazquez N., Martin-Lomas M., Reichardt N.-C. A new linker for solid-phase synthesis of heparan sulfate precursors by sequential assembly of monosaccharide building blocks. Chem. Commun. 2011, 47:2390-2392.
83. Ojeda R., Terenti O., de Paz J.-L., Martin-Lomas M. Synthesis of heparin-like oligosaccharides on polymer supports. Glycoconj. J. 2004, 21:179-195.
84. de Paz J.-L., Angulo J., Lassaletta J.-M., Nieto P.M., Redondo-Horcajo M., Lozano R.M., Gimenez-Gallego G., Martin-Lomas M. The activation of fibroblast growth factors by heparin: Synthesis, structure, and biological activity of heparin-like oligosaccharides. Chembiochem 2001, 2:673-685.
85. Prabhu A., Venot A., Boons G.-J. New set of orthogonal protecting groups for the modular synthesis of heparan sulfate fragments. Org. Lett. 2003, 5:4975-4978.
86. Lubineau A., Lortat-Jacob H., Gavard O., Sarrazin S., Bonnaffe D. Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-γ in the nanomolar range. Chem. Eur. J. 2004, 10:4265-4282.
87. Poletti L., Fleischer M., Vogel C., Guerrini M., Torri G., Lay L. A rational approach to heparin-related fragments-Synthesis of differently sulfated tetrasaccharides as potential ligands for fibroblast growth factors. Eur. J. Org. Chem. 2001, 2727-2734.
88. de Paz J.L., Martin-Lomas M. Synthesis and biological evaluation of a heparin-like hexasaccharide with the structural motifs for binding to FGF and FGFR. Eur. J. Org. Chem. 2005, 1849-1858.
89. Lucas R., Angulo J., Nieto P.M., Martin-Lomas M. Synthesis and structural study of two new heparin-like hexasaccharides. Org. Biomol. Chem. 2003, 1:2253-2266.
90. de Paz J.-L., Ojeda R., Reichardt N., Martin-Lomas M. Some key experimental features of a modular synthesis of heparin-like oligosaccharides. Eur. J. Org. Chem. 2003, 3308-3324.
91. Ojeda R., Angulo J., Nieto P.M., Martin-Lomas M. The activation of fibroblast growth factors by heparin: Synthesis and structural study of rationally modified heparin-like oligosaccharides. Can. J. Chem. 2002, 80:917-936.
92. Daragics K., Fëgedi P. Synthesis of glycosaminoglycan oligosaccharides. Part 5: Synthesis of a putative heparan sulfate tetrasaccharide antigen involved in prion diseases. Tetrahedron 2010, 66:8036-8046.
93. Cole C.L., Hansen S.U., Barath M., Rushton G., Gardiner J.M., Avizienyte E., Jayson G.C. Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. PLoS One 2010, 5:e11644.
94. Nguyen H.M., Poole J.L., Gin D.Y. Chemoselective iterative dehydrative glycosylation. Angew. Chem. Int. Ed. 2001, 40:414-417.
95. McDonnell C., Lopez O., Murphy P., Bolanos J.G.F., Hazell R., Bols M. Conformational effects on glycoside reactivity: Study of the high reactive conformer of glucose. J. Am. Chem. Soc. 2004, 126:12374-12385.
96. Jensen H.H., Nordstrom L.U., Bols M. The disarming effect of the 4,6-acetal group on glycoside reactivity: Torsional or electronic?. J. Am. Chem. Soc. 2004, 126:9205-9213.
97. Zhang Z., Ollmann I.R., Ye X.-S., Wischnat R., Baasov T., Wong C.-H. Programmable one-pot oligosaccharide synthesis. J. Am. Chem. Soc. 1999, 121:734-753.
98. Huang L., Wang Z., Huang X. One-pot oligosaccharide synthesis: Reactivity tuning by post-synthetic modification of aglycon. Chem. Commun. 2004, 1960-1961.
99. Pornsuriyasak P., Gangadharmath U.B., Rath N.P., Demchenko A.V. A novel strategy for oligosaccharide synthesis via temporarily deactivated S-thiazolyl glycosides as glycosyl acceptors. Org. Lett. 2004, 6:4515-4518.
100. Lahmann M., Oscarson S. Investigation of the reactivity difference between thioglycoside donors with variant aglycon parts. Can. J. Chem. 2002, 80:889-893.
101. Polat T., Wong C.-H. Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides. J. Am. Chem. Soc. 2007, 129:12795-12800.
102. Li X., Huang L., Hu X., Huang X. Thio-arylglycosides with various aglycon para-substituents: A probe for studying chemical glycosylation reactions. Org. Biomol. Chem. 2009, 7:117-127.
103. Park T.K., Kim I.J., Hu S., Bilodeau M.T., Randolph J.T., Kwon O., Danishefsky S.J. Total synthesis and proof of structure of a human breast tumor (Globo-H) antigen. J. Am. Chem. Soc. 1996, 118:11488-11500.
104. Yamago S., Yamada T., Hara O., Ito H., Mino Y., Yoshida J.-i. A new, iterative strategy of oligosaccharide synthesis based on highly reactive β-bromoglycosides derived from selenoglycosides. Org. Lett. 2001, 3:3867-3870.
105. Yamago S., Yamada T., Maruyama T., Yoshida J. Iterative glycosylation of 2-deoxy-2-amino- thioglycosides and its application to the combinatorial synthesis of linear oligo-glucosamines. Angew. Chem. Int. Ed. 2004, 43:2145-2148.
106. Huang X., Huang L., Wang H., Ye X.-S. Iterative one-pot synthesis of oligosaccharides. Angew. Chem. Int. Ed. 2004, 43:5221-5224.
107. Kuberan B., Lech M.Z., Beeler D.L., Wu Z.L., Rosenberg R.D. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat. Biotechnol. 2003, 21:1343-1346.
108. Chen J., Jones C.L., Liu J. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures with differing sulfation patterns. Chem. Biol. 2007, 14:986-993.
109. Chen J., Avci F.Y., Munoz E.M., McDowell L.M., Chen M., Pedersen L.C., Zhang L., Linhardt R.J., Liu J. Enzymatic redesigning of biologically active heparan sulfate. J. Biol. Chem. 2005, 280:42817-42825.
110. Lindahl U., Li J.-P., Kusche-Gullberg M., Salmivirta M., Alaranta S., Veromaa T., Emeis J., Roberts I., Taylor C., Oreste P., Zoppetti G., Naggi A., Torri G., Casu B. Generation of " Neoheparin" from E. coli K5 capsular polysaccharide. J. Med. Chem. 2005, 48:349-352.
111. Wang Z., Ly M., Zhang F., Zhong W., Suen A., Hickey A.M., Dordick J.S., Linhardt R.J. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol. Bioeng. 2010, 107:964-973.
112. Griffiths G., Cook N.J., Gottfridson E., Lind T., Lidholt K., Roberts I.S. Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site. J. Biol. Chem. 1998, 273:11752-11757.
113. Hodson N., Griffiths G., Cook N., Pourhossein M., Gottfridson E., Lind T., Lidholt K., Roberts I.S. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an α-UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J. Biol. Chem. 2000, 275:27311-27315.
114. Xu Y., Masuko S., Takieddin M., Xu H., Liu R., Jing J., Mousa S.A., Linhardt R.J., Liu J. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 2011, 334:498-501.
115. Liu R., Xu Y., Chen M., Weiwer M., Zhou X., Bridges A.S., De A.P.L., Zhang Q., Linhardt R.J., Liu J. Chemoenzymatic design of heparan sulfate oligosaccharides. J. Biol. Chem. 2010, 285:34240-34249.
116. Xu Y., Wang Z., Liu R., Bridges A.S., Huang X., Liu J. Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach. Glycobiology 2012, 22:96-106.